Clinical Trials Logo

Filter by:
NCT ID: NCT05163171 Completed - Addiction Clinical Trials

Prevalence of the Victimization and the Perpetration of Intimate Partner Violence Among the Patients From Puy-de-Dôme and Paris Consulting or Being Hospitalized for Addiction Problems and Their Expectations From General Practitioners (VIA-MG)

VIA-MG
Start date: January 10, 2022
Phase:
Study type: Observational

Intimate partner violence and addictions are two frequent problematics with many consequences on health. A link between intimate partner violence and addictions has been found in many studies. Being a drug user increases the risk to be a perpetrator and also a victim of intimate partner violence. So, it is legitimate to question ourselves about the prevalence of the victims and perpetrators of intimate partner violence among the patients consulting or being hospitalized for an addiction problem. We believe that this prevalence will be high among these patients. On the other hand, the general practitioners are in first line receiving victims and perpetrators of violence and patients with addiction problems. So it is important to know the profiles of these patients and their expectations from their general practitioners.

NCT ID: NCT05162599 Completed - Rhythm; Abnormal Clinical Trials

Evaluation of Cardiags Trimod for Analysis of Cardiac Activity

EVALTRIMOD
Start date: June 8, 2022
Phase: N/A
Study type: Interventional

The current study concerns Cardiags Trimod, a new non-invasive medical device for cardiac examinations. The evaluation of its effectiveness is done relative to specific standard devices.

NCT ID: NCT05161130 Completed - Low Back Pain Clinical Trials

Predicting Outcomes After Lumbar Fusion for Degenerative Disease

FUSE-ML
Start date: January 1, 2021
Phase:
Study type: Observational

The aim of the FUSE-ML study is to develop and externally validate a robust ML-based prediction tool based on multicenter data from a range of international centers that will provide individualized risk-benefit profiles tailored to each patient undergoing lumbar spinal fusion for degenerative disease. Data will be collected by a range of international centers.

NCT ID: NCT05160298 Completed - Postoperative Pain Clinical Trials

Analgesic Effect of Bilateral Erector Spinae Plane Block With Ropivacaine After Sternotomy for Cardiac Surgery

ESB-Sterno
Start date: October 20, 2021
Phase: Phase 2
Study type: Interventional

The sternotomy site is the most painful area after cardiac surgery. Erector spinae plane block is effective in thoracic and abdominal surgery, but literature is lacking in cardiac surgery. The bilateral erector spinae plane block could reduce pain at rest and during mobilization, reduce opioids consumption, decrease postoperative complications, improve respiratory outcomes and improve patient comfort and satisfaction. The research hypothesis is that a single shot bilateral erector spinae plane block could reduce pain during mobilization during the first 48 hours after cardiac surgery performed with sternotomy

NCT ID: NCT05160181 Completed - Chronic Pain Clinical Trials

Impact of Yogotherapeutics on Chronic Pains' Patients

YOGADO
Start date: September 13, 2021
Phase:
Study type: Observational

In a context where yoga is more and more popularized in France and in Europe, and where Yogatherapy (as complementary medicine) begins to make its place in the care of patients in French hospitals, it seems interesting to study the impact of yoga in the chronic pain patient treated in a specific pain consultation by this non-pharmacological approach, and accessible.

NCT ID: NCT05159908 Completed - Focal Onset Seizure Clinical Trials

A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

Start date: November 8, 2021
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety, pharmacokinetics, and efficacy of three different doses of NBI-921352 versus placebo in adults with focal onset seizures

NCT ID: NCT05159271 Completed - Nasal Congestion Clinical Trials

Efficacy and Safety of Azeol Nasal Spray Versus Placebo in the Treatment of Early Symptoms of Common Cold in Adults

EXSPRAY
Start date: November 22, 2021
Phase: N/A
Study type: Interventional

The main objective is to evaluate the efficacy of Azéol Spray Nasal, taken two times a day, versus placebo on nasal congestion in subject with common cold.

NCT ID: NCT05158764 Completed - Venous Leg Ulcer Clinical Trials

Efficacy and Safety of URGOBD001 Compression System

FUTURE
Start date: December 3, 2021
Phase: N/A
Study type: Interventional

Evaluation of the efficacy (wound epithelialization and time to closure) and safety (emergence and nature of adverse event) of the new URGO BD001 compression system versus a reference compression in the local treatment of venous or mixed predominantly venous leg ulcers: prospective multicenter, randomized controlled, open-label clinical study

NCT ID: NCT05158010 Completed - Health Behavior Clinical Trials

Advancing Tools for Human Early Lifecourse Exposome Research and Translation- Adolescence Follow-up of the HELIX Subcohort

ATHLETE
Start date: November 10, 2021
Phase: N/A
Study type: Interventional

ATHLETE will set up a prospective Europe-wide exposome cohort covering the first 2 decades of the life course, which will integrate data on the external, chemical, physical,behavioral, and social domains of the exposome, as well as on health outcomes and biological omics responses, from preconception until adolescence. As part of ATHLETE, the investigators will follow up a unique existing exposome cohort into adolescence (the HELIX Subcohort).

NCT ID: NCT05157633 Completed - Infant Development Clinical Trials

Oral Exploration of Objects and Food Diversification

OPENING
Start date: September 15, 2021
Phase:
Study type: Observational

Eating difficulties in infants and young children are defined as all the difficulties in feeding oneself in an appropriate and satisfactory manner. These disorders affect approximately 20 to 25% of infants and young children, and thus constitute one of the most frequent reasons for consultation in these age groups. Many of these children continue to be received in consultation. Studies show that the lack of intraoral exploration in children could be associated with later difficulties in accepting different textures or new foods. Our clinical examination of sensorimotor functions shows signs of sensory hyper reactivity that are very common in children who always wipe their hands when in contact with food or sticky objects and for those who experience difficulty in brushing or grooming themselves. In all of the publications available which includes pubmed, there is no mention of the lack of exploration of objects and the stigma of sensory hyper-responsiveness even if this latter was not entirely detailed in the descriptions made. The trial hypothesis is that this exploration defect corresponds to early sensory hyperreactivity which also plays a deleterious role in the acceptance of new textures and new foods. In this trial we propose a comparison study with a controlled population of children without eating difficulties as defined by the Montreal MCH score to validate a statistical link between the difficulties in food diversification beyond 18 months and the lack of exploration of the environment with 'mouthing' between 6 and 10 months. Investigators will analyse consultation questionnaires dedicated to eating difficulties retrospectively (patients) and will compare them with questionnaires of children from daycares without eating difficulties (controls).